Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Ming Xu

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Research in Microbiology|August 13, 2008
A putative colR(XC1049)-colS(XC1050) two-component signal transduction system in Xanthomonas campestris positively regulates hrpC and hrpE operons and is involved in virulence, the hypersensitive response and tolerance to various stressesSui-Sheng Zhang, Yong-Qiang He, Li-Ming Xu, et al.
Blood|June 26, 2015
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter studyYong Yang, Yuan Zhu, Jian-Zhong Cao, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 26, 2014
[Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models]Qing-Cui Li, Xiao-Hui Han, Bing Zhou, et al.
JAMA Oncology|November 29, 2016
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell LymphomaYong Yang, Jian-Zhong Cao, Sheng-Min Lan, et al.
Leukemia & Lymphoma|May 8, 2019
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG)Shu-Nan Qi, Li-Ming Xu, Zhi-Yong Yuan, et al.
Cancer Medicine|October 26, 2018
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Bo Chen, Su-Yu Zhu, Mei Shi, et al.
Aging|October 7, 2019
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)Wei-Xin Liu, Mei Shi, Hang Su, et al.
JAMA Network Open|March 2, 2019
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell LymphomaXin Liu, Tao Wu, Su-Yu Zhu, et al.
Blood Advances|September 23, 2018
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative GroupTao Wu, Yong Yang, Su-Yu Zhu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2018
Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Research in Microbiology|August 13, 2008
A putative colR(XC1049)-colS(XC1050) two-component signal transduction system in Xanthomonas campestris positively regulates hrpC and hrpE operons and is involved in virulence, the hypersensitive response and tolerance to various stressesSui-Sheng Zhang, Yong-Qiang He, Li-Ming Xu, et al.
Blood|June 26, 2015
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter studyYong Yang, Yuan Zhu, Jian-Zhong Cao, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 26, 2014
[Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models]Qing-Cui Li, Xiao-Hui Han, Bing Zhou, et al.
JAMA Oncology|November 29, 2016
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell LymphomaYong Yang, Jian-Zhong Cao, Sheng-Min Lan, et al.
Leukemia & Lymphoma|May 8, 2019
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG)Shu-Nan Qi, Li-Ming Xu, Zhi-Yong Yuan, et al.
Cancer Medicine|October 26, 2018
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Bo Chen, Su-Yu Zhu, Mei Shi, et al.
Aging|October 7, 2019
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG)Wei-Xin Liu, Mei Shi, Hang Su, et al.
JAMA Network Open|March 2, 2019
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell LymphomaXin Liu, Tao Wu, Su-Yu Zhu, et al.
Blood Advances|September 23, 2018
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative GroupTao Wu, Yong Yang, Su-Yu Zhu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2018
Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, et al.
Pageof 9